$SABS Cashflow Statement | Understand Stock

$SABS

$2.79 -$0.05 (1.76%) Close

$SABS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on debt extinguishment of Paycheck Protection Program SBA Loan
Depreciation and amortization
Amortization of right-of-use assets
Amortization of finance right-of-use assets
Stock-based compensation expense
Gain on sale of equipment
Gain on partial lease termination
Loss on private placement issuance
Gain from private placement warrant termination
Net realized and unrealized gain on investment in short-term securities
Changes in fair value of warrant liabilities
Accretion of discounts on short-term investments
Professional fees settled with equity instruments
Write-off of deferred issuance costs
Changes in operating assets and liabilities
Accrued interest receivable
Accounts receivable
Prepaid expenses
Operating lease right-of-use assets
Prepaid expenses and other current assets
Operating lease right-of-use assets and liabilities, net
Accounts payable
Due to related party
Deferred grant income
Accrued expense and other current liabilities

Net cash used in operating activities
Cash flows from investing activities:
Proceeds from the sale of equipment
Purchases of equipment
Purchases of investment securities
Sales and maturities of investments
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from Business Combination, net of transaction costs
Proceeds from issuance of common stock
Proceeds from private placement issuance of preferred stock and warrants
Proceeds from exercise of private placement preferred warrants
Payments related to the Forward Share Purchase Agreement
Proceeds from the 2025 PIPE, net of Series B issuance costs
Payment of deferred issuance costs
Proceeds from issuance of notes payable
Payments of notes payable
Principal payments of notes payable
Principal payments on finance leases
Proceeds from exercise of stock options
Tax payments for share settlement of restricted stock units
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents
Beginning of period
End of period
Supplemental cash flow information:
Cash paid for interest
Cash paid for income taxes

Supplemental information on non-cash investing and finance activities:
Right-of-use assets obtained in exchange for operating lease liabilities
Warrant liabilities assumed related to the Business Combination
Liabilities assumed related to the Forward Share Purchase Agreement
Financing fee liabilities assumed related to the Business Combination included in accrued expense and other current liabilities
Unpaid financing fees included in accrued expense and other current liabilities
Right-of-use assets forfeited due to partial lease terminations
Operating lease liabilities eliminated due to partial lease terminations
Note payable issued in consideration for abated lease payments
Settlement of accrued liabilities through the issuance of common stock
Issuance of common stock for prepaid marketing and investor related consulting services
Fair value of private placement preferred warrant liability associated with warrant exercise
Deferred issuance costs included in accrued expenses
Reclassification of warrants from liability to equity
Reclassification of Redeemable Preferred Stock to Permanent Equity upon Requisite Approval

Comments